COVID-19 and cystic fibrosis: diagnostic difficulties or incorrect methods?

Vista sencilla de ítem
dc.date.accessioned2023-04-05T12:48:27Z
dc.date.available2023-04-05T12:48:27Z
dc.date.issued2020
dc.description.abstractCystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic. © The Author(s) 2020.
dc.identifier.issn9737510
dc.identifier.urihttps://doi.org/10.22207/JPAM.14.3.06
dc.identifier.urihttp://146.190.124.33/handle/123456789/6386
dc.language.isoenges_ES
dc.publisherJournal of Pure and Applied Microbiologyes_ES
dc.sourceRevista de Biologia Tropical; Vol. 69 Núm. 4
dc.titleCOVID-19 and cystic fibrosis: diagnostic difficulties or incorrect methods?es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersion
Archivos
Colecciones
Artículo